Earnings summaries and quarterly performance for Bath & Body Works.
Executive leadership at Bath & Body Works.
Board of directors at Bath & Body Works.
Alessandro Bogliolo
Director
Danielle Lee
Director
Francis Hondal
Director
J.K. Symancyk
Director
Juan Rajlin
Director
Lucy Brady
Director
Sarah Nash
Independent Chair of the Board
Stephen Steinour
Director
Steven Voskuil
Director
Research analysts who have asked questions during Bath & Body Works earnings calls.
Alex Straton
Morgan Stanley
7 questions for BBWI
Dana Telsey
Telsey Advisory Group
7 questions for BBWI
Matthew Boss
JPMorgan Chase & Co.
7 questions for BBWI
Mark Altschwager
Robert W. Baird & Co.
6 questions for BBWI
Olivia Tong Cheang
Raymond James Financial, Inc.
5 questions for BBWI
Ike Boruchow
Wells Fargo
4 questions for BBWI
Jonna Kim
TD Cowen
4 questions for BBWI
Korinne Wolfmeyer
Piper Sandler & Co.
4 questions for BBWI
Lorraine Hutchinson
Bank of America
4 questions for BBWI
Paul Lejuez
Citigroup
4 questions for BBWI
Ashley Helgans
Jefferies
3 questions for BBWI
Katharine McShane
Goldman Sachs Group, Inc.
3 questions for BBWI
Kelly Crago
Citigroup Inc.
3 questions for BBWI
Krisztina Katai
Deutsche Bank AG
3 questions for BBWI
Lorraine Maikis
Bank of America
3 questions for BBWI
Marni Shapiro
The Retail Tracker
3 questions for BBWI
Simeon Siegel
BMO Capital Markets
3 questions for BBWI
Irwin Boruchow
Wells Fargo Securities
2 questions for BBWI
Jay Sole
UBS
2 questions for BBWI
Jungwon Kim
BTIG, LLC
2 questions for BBWI
Kate McShane
Goldman Sachs
2 questions for BBWI
Olivia Tong
Raymond James
2 questions for BBWI
Adrianne Yih
Barclays PLC
1 question for BBWI
Adrian Yee
Barclays PLC
1 question for BBWI
Adrienne Yih-Tennant
Barclays
1 question for BBWI
Natalie May Koltermann
UBS Group AG
1 question for BBWI
Sydney Wagner
Jefferies
1 question for BBWI
Recent press releases and 8-K filings for BBWI.
- Faruqi & Faruqi, LLP is investigating potential claims against Bath & Body Works (BBWI) for alleged federal securities law violations, with a deadline of March 16, 2026, for investors to seek the role of lead plaintiff.
- The class action covers investors who purchased or acquired securities between June 4, 2024, and November 19, 2025.
- The complaint alleges that the company's strategy of "adjacencies, collaborations and promotions" failed to grow its customer base and net sales, leading to reliance on collaborations to "carry quarters" and obfuscate weak financial results, and that positive statements were materially misleading.
- These issues were highlighted when Bath & Body Works announced disappointing third quarter 2025 financial results on November 20, 2025, reporting a 1% year-over-year decline in revenue, a 26% drop in net income to $77 million, and a sharply reduced full-year EPS outlook from a range of $3.28-$3.53 to "at least $2.83".
- Following these disclosures, BBWI's stock price fell $5.22, or 24.8%, to close at $15.82 per share on November 20, 2025.
- Bath & Body Works officially launched its authorized storefront on Amazon's U.S. stores on February 20, 2026, making a curated selection of its body care and home fragrances available to consumers.
- This launch is a key component of the brand's "Consumer First Formula," a strategic transformation plan introduced in November 2025, aimed at expanding access and ease of discovery through third-party channels.
- The brand is simultaneously unveiling an evolved brand identity on Amazon, which will subsequently be rolled out to its owned channels later in the year.
- Faruqi & Faruqi, LLP is investigating potential claims against Bath & Body Works (BBWI) and reminds investors of the March 16, 2026 deadline to seek the role of lead plaintiff in a federal securities class action.
- The class action covers investors who purchased or acquired securities in Bath & Body Works between June 4, 2024 and November 19, 2025.
- The complaint alleges that the company's strategy of "adjacencies, collaborations and promotions" failed to grow the customer base or deliver touted net sales growth, leading to reliance on collaborations to "carry quarters" and obfuscate weak underlying financial results.
- On November 20, 2025, Bath & Body Works announced disappointing Q3 2025 financial results, including a 1% year-over-year revenue decline and a 26% drop in net income to $77 million, and sharply reduced its full-year EPS outlook from a range of $3.28-$3.53 to "at least $2.83".
- Following these disclosures, Bath & Body Works' stock price fell $5.22, or 24.8%, to close at $15.82 per share on November 20, 2025.
- Faruqi & Faruqi, LLP is investigating potential claims against Bath & Body Works (BBWI) and reminds investors of the March 16, 2026 deadline to seek the role of lead plaintiff in a federal securities class action.
- The lawsuit alleges that the company made false and/or misleading statements, failing to disclose that its strategy was not growing the customer base or net sales, relied on collaborations to "carry quarters," and was unlikely to meet its financial guidance.
- On November 20, 2025, Bath & Body Works announced disappointing Q3 2025 financial results, including a 1% year-over-year decline in revenue, a 26% drop in net income to $77 million, and a reduced full-year earnings per diluted share outlook from a range of $3.28-$3.53 to "at least $2.83".
- Following these disclosures, Bath & Body Works' stock price fell $5.22, or 24.8%, to close at $15.82 per share on November 20, 2025.
- Faruqi & Faruqi, LLP is investigating Bath & Body Works for alleged federal securities law violations, encouraging investors who purchased securities between June 4, 2024, and November 19, 2025, to discuss their legal rights.
- Investors have until March 16, 2026, to seek the role of lead plaintiff in the federal securities class action.
- The complaint alleges the company's strategy of "adjacencies, collaborations and promotions" failed to grow its customer base and obscured weak underlying financial results, leading to misleading statements.
- On November 20, 2025, Bath & Body Works announced disappointing third quarter 2025 financial results, including a 1% year-over-year decline in revenue and a 26% drop in net income to $77 million, and sharply reduced its full-year earnings guidance.
- Following these disclosures, Bath & Body Works' stock price fell $5.22, or 24.8%, to close at $15.82 per share on November 20, 2025.
- Faruqi & Faruqi, LLP is investigating Bath & Body Works for a federal securities class action, with a March 16, 2026, deadline for lead plaintiff applications, concerning securities purchased between June 4, 2024, and November 19, 2025.
- The complaint alleges the company's "adjacencies, collaborations and promotions" strategy failed to grow its customer base and net sales, leading to misleading statements and reliance on collaborations to obscure weak financial results.
- On November 20, 2025, Bath & Body Works reported disappointing Q3 2025 financial results, including a 1% year-over-year revenue decline and a 26% drop in net income to $77 million, missing prior guidance.
- Concurrently, the company reduced its full-year earnings per diluted share outlook from $3.28-$3.53 to "at least $2.83".
- Following these disclosures, Bath & Body Works' stock price fell $5.22, or 24.8%, to $15.82 per share on November 20, 2025.
- Faruqi & Faruqi, LLP is investigating Bath & Body Works (BBWI) for potential federal securities law violations, with a March 16, 2026 deadline for investors to seek lead plaintiff status in a class action covering securities purchased between June 4, 2024, and November 19, 2025.
- The complaint alleges that the company's strategy of "adjacencies, collaborations and promotions" failed to grow its customer base or deliver expected net sales growth, leading to reliance on collaborations to "carry quarters" and obfuscate weak financial results.
- On November 20, 2025, Bath & Body Works announced disappointing Q3 2025 financial results, including a 1% year-over-year decline in revenue and a 26% drop in net income to $77 million, missing prior guidance.
- The company also sharply reduced its full-year earnings per diluted share outlook from a range of $3.28 to $3.53 to "at least $2.83," which resulted in its stock price falling 24.8% on November 20, 2025.
- Faruqi & Faruqi, LLP is investigating Bath & Body Works (BBWI) and a federal securities class action has been filed, with a March 16, 2026, deadline for investors who purchased securities between June 4, 2024, and November 19, 2025, to seek lead plaintiff status.
- The complaint alleges the company made false or misleading statements about its strategy, which failed to grow the customer base and led to an overreliance on collaborations to obscure weak financial results and an inability to meet financial guidance.
- On November 20, 2025, Bath & Body Works reported a 1% year-over-year revenue decline and a 26% drop in net income to $77 million for Q3 2025, missing prior guidance, and reduced its full-year earnings per diluted share outlook to "at least $2.83".
- Following these disclosures, Bath & Body Works' stock price fell $5.22, or 24.8%, to close at $15.82 per share on November 20, 2025.
- Faruqi & Faruqi, LLP is investigating Bath & Body Works (BBWI) for potential federal securities law violations concerning statements made between June 4, 2024, and November 19, 2025.
- The investigation follows BBWI's announcement of disappointing Q3 2025 financial results on November 20, 2025, which included a 1% year-over-year revenue decline and a 26% drop in net income to $77 million, leading to a 24.8% stock price decline.
- Allegations include that the company's strategy of "adjacencies, collaborations and promotions" failed to grow the customer base and that the company relied on collaborations to "carry quarters" and obfuscate weak underlying financial results, making previously issued financial guidance unlikely to be met.
- Investors who purchased securities during the specified period have until March 16, 2026, to seek the role of lead plaintiff in the federal securities class action.
- Bath & Body Works (BBWI) is implementing a "Consumer-First Formula" strategy with four pillars: creating innovative products in core categories, reigniting the brand, winning in the marketplace (including digital expansion), and improving internal efficiency. This follows previous strategies, such as moving into adjacencies, which did not achieve expected growth or new customer acquisition.
- The company is focused on significantly improving its digital presence, including a new mobile homepage, native app, enhanced product photography, and establishing an official presence on Amazon to capture market share and address existing grey market sales.
- For 2026, BBWI does not expect to return to growth for the full year, with strategic initiatives anticipated to become visible in the first half but having a greater financial impact in the second half.
- Management expects stable consumer demand but more headwinds for margins over the next 12 months.
Quarterly earnings call transcripts for Bath & Body Works.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more